Related references
Note: Only part of the references are listed.Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel
Zeev Meiner et al.
JOURNAL OF NEUROLOGY (2011)
Elevated Levels of Tau Protein in Cerebrospinal Fluid of Patients With Probable Creutzfeldt-Jakob Disease
Gui-Rong Wang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review
G. Chohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Rapidly Progressive Neurodegenerative Dementias
Keith A. Josephs et al.
ARCHIVES OF NEUROLOGY (2009)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
EFNS guidelines on disease-specific CSF investigations
F. Deisenhammer et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients
Ines Esteves Baldeiras et al.
JOURNAL OF NEUROLOGY (2009)
14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes
K. Gmitterova et al.
NEUROBIOLOGY OF AGING (2009)
The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease
Catherine Pennington et al.
NEUROSCIENCE LETTERS (2009)
Rapidly progressive dementia
Michael D. Geschwind et al.
ANNALS OF NEUROLOGY (2008)
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies
A. Green et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Detection of CSF 14-3-3 protein in Guillain-Barre syndrome
A. Bersano et al.
NEUROLOGY (2006)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Cerebral amyloidoses: Molecular pathways and therapeutic challenges
Salvatore Monaco et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Phosphorylated 14-3-3ξ protein in the CSF of neuroleptic-treated patients
G Zanusso et al.
NEUROLOGY (2005)
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
M Grossman et al.
ANNALS OF NEUROLOGY (2005)
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes
G Zanusso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease
RJ Castellani et al.
NEUROLOGY (2004)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
M Riemenschneider et al.
MOLECULAR PSYCHIATRY (2003)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease
I Zerr et al.
NEUROLOGY (2000)
Share Paper
